Benefits of remote real-time side-effect monitoring systems for patients receiving cancer treatment

Oncology Reviews

Volumn 6, Issue 1, 2012, Pages 51-63

  Kofoed, Sarah ^a   Breen, Sibilah ^a,b   Gough, Karla ^a   Aranda, Sanchia ^a,b,c  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

^b THE UNIVERSITY OF MELBOURNE   (Australia)

^c CANCER INSTITUTE NSW   (Australia)

Author keywords

Cancer; Chemotherapy; Remote monitoring; Toxicities

Indexed keywords

CANCER PATIENT; CANCER THERAPY; CHRONIC DISEASE; COST EFFECTIVENESS ANALYSIS; DEPRESSION; DIARRHEA; DIGESTIVE SYSTEM FUNCTION DISORDER; FATIGUE; FEBRILE NEUTROPENIA; HEALTH CARE SYSTEM; HUMAN; MUCOSA INFLAMMATION; NAUSEA; OUTCOME ASSESSMENT; PAIN; PATIENT COMPLIANCE; PRIORITY JOURNAL; REVIEW; TELEMEDICINE; VOMITING;

EID: 84878661740     PISSN: 19705557     EISSN: 19705565     Source Type: Journal    
DOI: 10.4081/oncol.2012.e7     Document Type: Review

References (51)

1. Australian Institute of Health and Welfare & Australasian Association of Cancer Registries 2010. Cancer in Australia: in brief 2010. Cancer series no. 59, 2010; Cat. No. CAN 55. Canberra: AIHW.
2. Hesketh PJ, Sanz-Altamira P, Bushey J, Hesketh AM. Prospective evaluation of the incidence of delayed nausea and vomiting in patients with colorectal cancer receiving oxaliplatin-based chemotherapy. Support Care Cancer 2012; 5; 1043-7.
3. Jones JM, Qin R, Bardia A, et al. Antiemetics for chemotherapy-induced nausea and vomiting occurring despite prophylactic antiemetic therapy. J Pall Med 2011; 14:810-4.
4. Blanke CD, Bot BM, Thoman DM, et al. Impact of young age on treatment efficacy and safety in advanced colorectal cancer: a pooled analysis of patients from Nine First-Line Phase III Chemotherapy Trials. J Clin Onc 2011; 29:2781-6.
5. Ridolfi L, Bertetto o, Santo A, et al. Chemotherapy with or without low-dose interleukin-2 in advanced non-small cell lung cancer: results from a phase III randomized multicentric trial. Int J Onc 2011; 39:1011-7.
6. Madarnas Y, Dent SF, Husain SF, et al. Real-world experience with adjuvant fec-d chemotherapy in four Ontario regional cancer centres. Curr Onc 2011; 18:119-25.
7. Lanoix, JP, Pluquet E, Lescure FX, et al. Bacterial infection profiles in lung cancer patients with febrile neutropenia. BMC Infect Dis 2011; 11:183.
8. Kuderer NM, Dale DC, Crawford J. Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients. Cancer 2006; 106:2258-66.
9. Park VJ, Trovoto JA. Frequency of nausea and vomiting after chemotherapy. Am J Health Syst Pharm 2004; 61:722-3.
10. Du XL, Osborne C, Goodwin JS. Population-based assessment of hospitalizations for toxicity from chemotherapy in older women with breast cancer. J Clin Oncol 2002; 20:4636-42.
11. Richardson A, Ream E. The experience of fatigue and other symptoms in patients receiving chemotherapy. Eur J Cancer Care 1996; 5:24-30.
12. Scully C, Sonis S, Diz PD. Oral mucositis. Oral Dis 2006; 12:229-41.
13. Sonis S, Oster G, Fuchs H. Oral mucositis and the clinical and economic outcomes of haematopoietic stem-cell transplantation. J. Clin. Oncol 2001; 19:2201-5.
14. Glaus A. Assessment of fatigue in cancer and non-cancer patients and in health individuals. Support Care Cancer 1993; 1:305-15.
15. Fransson P. Fatigue in prostate cancer patients treated with external beam radiotherapy: a prospective 5-year long-term patient-reported evaluation. J Cancer Res Ther 2010; 6:516-20.
16. Henson C. Chronic radiation proctitis: issues surrounding delayed bowel dysfunction post-pelvic radiotherapy and an update on medical treatment. Therap Adv Gastroenterol 2010; 3:359-65.
17. Shapiro CL, Recht A. Side effects of adjuvant treatment of breast cancer. N Engl J Med 2001; 344:1997-2008.
18. Zachariah B, Balducci L, Venkattaramanabalaji GV, et al. Radiotherpy for cancer pateints aged 80 and lder: a study of effectiveness and side-effects. Int J Rad Onc Biol Phys 1997; 39:1125-9.
19. Trotti A, Belim LA, Epstein JB, et al. Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review. Rad Onc 2003; 66:253-62.
20. Katz J, Poleshuck EL, Andrus CH, et al. Risk factors for acute pain and its persistence following breast cancer surgery. Pain 2005; 119:16-25.
21. Breen SJ, Baravelli CM, Schofield PE, et al. Is symptom burden a predictor of anxiety and depression in patients with cancer about to commence chemotherapy? Med J Aust 2009; 190:586-9.
22. Barnett T, Chumbler N, Vogel W. The effectiveness of a care coordination home telehealth program for veterans with diabetes melli-tus: a 2-year follow-up. Am J Manag Care 2006; 12:4467-74.
23. Chumbler N, Neugaard B, Kobb R. Evaluation of a care coordination/home- telehealth program for veterans with diabetes. Eval Health Prof 2005; 28:464-78.
24. Rasmussen LM, Phanareth K, Nolte H, Backer V. Internet-based monitoring of asthma: a long-term, randomized clinical study of 300 asthmatic subjects. J All Clin Immunol 2005; 115:1137-42.
25. Louis A, Turner T, Gretton M, et al. A systematic review of tele-monitoring for the management of heart failure. Eur J Heart Fail 2003; 5:583-90.
26. Bartoli L, Zanaboni P, Masella C, Ursini N. Systematic review of telemedicine services for patients affected by chronic obstructive pulmonary disease (COPD). Telemed J E Health 2009; 15:877-83.
27. Santamaria N, Carville K, Ellis I, Prentice J. The effectiveness of digital imaging and remote wound consultation on healing rates in chronic lower leg ulcers in the Kimberley region of Western Australia. Prim Intent 2004; 12:62-70.
28. Noel HC, Vogel DC, Erdos JJ, et al. Home telehealth reduces healthcare costs. Telemed J E Health 2004; 10:170-83.
29. Cleeland JGF, Louis AA, Rigby AS, et al. Noninvasive home telemon-itoring for patients with heart failure at high risk of recurrent admission and death: the Trans-European Network-Home-Care Management System (TEN-HMS) study. J Am Coll Cardiol 2005; 45:1654-64.
30. Kearney N, Miller M, Maguire R, et al. WISECARE+: Results of a European study of a nursing intervention for the management of chemotherapy-related symptoms. Euro J Onc Nurs 2008; 12:443-8.
31. Mooney K, Beck S, Friedman R, Farzanfar R. Telephone-linked care for cancer symptom monitoring, a pilot study. Cancer Pract 2002; 10:147-54.
32. Lind L, Karlsson D. A system for symptom assessment in advanced palliative home healthcare using digital pens. Med Inform 2004; 29:199-210.
33. Lind L, Karlsson D, Fridlund B. Digital pens and pain diaries in palliative home healthcare: professional caregivers experience. Med Inform Internet Med 2007; 32:287-96.
34. Lind L, Karlsson D, Fridlund B. Patients' use of digital pens for pain assessment in advanced palliative home healthcare. Int J Med Inform 2008; 77:129-136.
35. McGee MR Gray P. A handheld chemotherapy symptom management system: results from a preliminary outpatient field trial. Health Info J 2005; 11:243-58.
36. Kearney N, Kidd L, Miller M, et al. Utilising handheld computers to monitor and support patients receiving chemotherapy: results of a UK based feasibility study. Support Care Cancer 2006; 14:742-52.
37. Maguire R, Miller M, Sage M, et al. Results of a UK based pilot study of a mobile phone based advanced symptom management system (ASyMS©) in the remote monitoring of chemotherapy related toxicity. Clin Effect Nurs 2005; 9:202-10.
38. Maguire R, McCann L, Miller M, Kearney N. Nurse's perceptions and experiences of using of a mobile-phone-based Advanced Symptom Management System (ASyMS©) to monitor and manage chemotherapy-related toxicity. Eur J Onc Nurs 2008; 12:380-6.
39. McCann L, Maguire R, Miller M, Kearney K. Patients' perceptions and experiences of using a mobile phone-based advanced symptom management system (ASyMS©) to monitor and manage chemotherapy related toxicity. Eur J Cancer Care 2009; 18:156-64.
40. McCall K, Keen J, Farrer K, et al. Perceptions of the use of a remote monitoring system in patients receiving palliative care at home. Int J Pall Nurs 2008; 14:426-31.
41. Gibson F, Aldiss S, Taylor RM, et al. Involving health professionals in the development of an advanced symptom management system for young people: the ASyMS-YG study. Eur J Onc Nurs 2009; 13:187-92.
42. Gibson F, Aldiss S, Taylor RM, et al. Utilization of the Medical Research Council evaluation framework in the development of technology for symptom management: the ASyMS-YG© Study. Cancer Nurs 2010; 33:343-52.
43. Weaver A, Young AM, Rowntree J, et al. Application of mobile phone technology for managing chemotherapy-associated side-effects. Ann Oncol 2007; 18:1887-92.
44. Head BA, Studts JL, Bumpous JM, et al. Development of a tele-health intervention for head and neck cancer patients. Telemed J E-Health 2009; 15:44-52.
45. Head BA, Keeney C, Studts JL, et al. Feasibillity and acceptance of a telehealth intervention to promote symptom management during treatment for head and neck cancer. J Support Oncol 2011; 9:e1-11.
46. Merlin T, Weston A, Tooher R. Extending an evidence hierachy to include topics other than treatment: revising Australian levels of evidence. BMC Med Res Meth 2009; 9:34-41.
47. Chumbler NR, Mkanta WN, Richardson LC, et al. Remote patient-provider communication and quality of life: empirical test of a dialogic model of cancer care. J Telemed Telecare 2007; 13:20-5.
48. Chumbler NR, Kobb R, Harris L, et al. Healthcare utilization among veterans undergoing chemotherapy: the impact of a cancer care coordination/home-telehealth program. J Amb Care Manage 2007; 30:308-17.
49. Kearney N, McCann L, Norrie J, et al. Evaluation of a mobile phone-based, advanced symptom management system (ASyMS) in the management of chemotherapy-related toxicity. Support Care Cancer 2009; 17:437-44.
50. Kroenke K, Theobald D, Wu J, et al. Effect of telecare management on pain and depression in patients with cancer: a randomized trial. JAMA 2010; 304:163-71.
51. Cleeland CS, Wang XS, Shi Q, et al. Automated symptom alerts reduce postoperative symptom severity after cancer surgery: a randomized controlled clinical trial. J Clin Onc 2011; 29:994-1000.